Overview

Dose Escalation and Pharmacokinetic Study of Paclitaxel Liposome Injection in Treating Patients With Advanced Solid Tumor After Failure From Conventional Treatments

Status:
Unknown status

Trial end date:
1969-12-31

Target enrollment:

Participant gender:

Summary

The purpose of this study is to determine the maximum tolerated dose (MTD)of paclitaxel liposome injection and to compare the pharmacokinetic characters between paclitaxel liposome injection and paclitaxel injection and to value the effectiveness for cancer treatment.

Phase:

Phase 4

Details

Lead Sponsor:

Nanjing Luye Sike Pharmaceutical Co., Ltd.
Nanjing Luye Sike Pharmaceutical Co.,Ltd.

Treatments:

Albumin-Bound Paclitaxel
Paclitaxel